Alternatives · ranked for first-timers
SnagRx lands at #95 in our ranking with a Mama-Match Score of 62/100. If it is not the right fit, here are the strongest alternatives for a GLP-1 first step — judged on the same first-timer rubric of a gentle start, honest pricing, real clinician support, access, ongoing help and fair cancellation.
Featured referral partner
Mama-Match
Compounded semaglutide and tirzepatide with advertised flat prices; clarify the offer and renewal rules before paying.
Rank #1 · Grade B
Mama-Match
Pallas refills cost $199/$299 every four weeks after initial offers; annual averages and the six-month refund promise have conditions.
Rank #2 · Grade B
Mama-Match
Semaglutide $175/mo and tirzepatide $235/mo; no dose surcharge within your plan. Annual savings require prepayment and strict refund limits.
Rank #3 · Grade B
Mama-Match
$179/mo for either medication, flat across doses, with a genuinely gentle microdose tier — if you can live with an annual plan and a pharmacy it will not name.
Rank #4 · Grade B
Mama-Match
Brand only: Wegovy pill from about $149/mo, Zepbound about $349–$499/mo, with a real video visit — pricier and with more moving parts than a flat compounded plan, but transparent.
Rank #5 · Grade B−
Mama-Match
Injections from $199 without a molecule-specific price or period; named partners and purchase terms need clarification.
Rank #6 · Grade B−
Mama-Match
$249/mo semaglutide, $329/mo tirzepatide with no commitment ($212 and $280 on the 12-month plan), a named Medical Director and a real video visit before anything is prescribed.
Rank #7 · Grade B−
Mama-Match
A physician-led obesity medicine program paired with a registered dietitian, with monthly video visits and a real effort to work your insurance — the $299 self-pay fee is for that clinical team, not the medication.
Rank #8 · Grade B−
Mama-Match
The Edit publishes $259/month for semaglutide and $349 for tirzepatide, alongside prepaid packages and an introductory offer that needs clarification.
Rank #9 · Grade B−
Mama-Match
Hers offers branded GLP-1s with messaging follow-up; the real bill combines medication and a required membership. Its company received FDA warning letter #716825 in September 2025.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. The scores are our editorial judgment under the methodology. Not medical advice; see our disclosure.
